In Vivo Toxicology Global Market Report 2026

In vivo toxicology is a field of toxicology that examines the effects of chemical, biological, or physical agents on living organisms under controlled conditions. This approach emphasizes understanding how substances interact with complex biological systems, allowing the evaluation of physiological, biochemical, and behavioral changes within an intact organism.

The main products in in vivo toxicology include consumables and instruments. In vivo toxicology consumables consist of materials such as reagents, animal feed, and sample containers used in experiments on live organisms to evaluate the safety or toxicity of substances. This field involves various types of testing, including chronic toxicity, sub-chronic toxicity, sub-acute toxicity, and acute toxicity testing, and employs multiple methodologies such as in vivo animal models, genetically modified organisms, non-human primate studies, rodent models, and larger mammals. It is applied to areas such as immunotoxicity, systemic toxicity, carcinogenicity, genotoxicity, developmental and reproductive toxicity (DART), and others, and serves a range of end users including pharmaceutical companies, biosimilar manufacturers, contract research organizations (CROs), academic and research institutions, and biotechnology firms.

Tariffs have impacted the in vivo toxicology market by increasing the cost of imported laboratory instruments, consumables, and specialized reagents. Segments such as imaging systems, flow cytometers, and animal monitoring equipment are most affected, with regions like Asia-Pacific including China and India facing significant import duties. This has led to higher operational costs and supply chain disruptions. On the positive side, tariffs have encouraged local manufacturing of consumables and instruments, fostering innovation and domestic production capacity growth.

The in vivo toxicology market research report is one of a series of new reports from The Business Research Company that provides in vivo toxicology market statistics, including in vivo toxicology industry global market size, regional shares, competitors with a in vivo toxicology market share, detailed in vivo toxicology market segments, market trends and opportunities, and any further data you may need to thrive in the in vivo toxicology industry. This in vivo toxicology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in vivo toxicology market size has grown strongly in recent years. It will grow from $5.61 billion in 2025 to $6 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to limited availability of standardized animal models, reliance on manual laboratory procedures, growing pharmaceutical R&D activities, increasing prevalence of chronic disease studies, adoption of basic imaging and analytical instruments.

The in vivo toxicology market size is expected to see strong growth in the next few years. It will grow to $7.79 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to development of genetically modified organisms for targeted studies, integration of automated and high-throughput screening systems, rising CRO outsourcing for toxicology testing, advancements in in vivo imaging and monitoring technologies, increasing focus on alternative models and reduction of animal testing. Major trends in the forecast period include growing adoption of rodent and non-human primate models, rising demand for advanced toxicology assay kits and reagents, expansion of immunotoxicity and genotoxicity testing services, increasing use of automated liquid handling and imaging systems, enhanced regulatory compliance and ethical standards in animal testing.

The growing number of drug discoveries is expected to drive the expansion of the in vivo toxicology market in the coming years. Drug discovery involves the scientific identification and design of new compounds that could serve as treatments or preventive measures for various diseases. Advances in biotechnology have significantly accelerated this process by improving the understanding of disease mechanisms and enabling the development of more targeted therapies. In vivo toxicology plays a crucial role in drug discovery by assessing the safety, tolerability, and potential adverse effects of investigational compounds in whole organisms. It helps identify dose-limiting toxicities and guides formulation and dosing strategies before clinical development. For example, in November 2024, the Patented Medicine Prices Review Board (PMPRB), a Canada-based government agency, reported that over 12,000 new medicines were in clinical trials in 2023, up from around 9,000 in 2022, with oncology accounting for 33% of the pipeline and infectious and central nervous system diseases representing 13% and 12%, respectively. This indicates that the increasing number of drug discoveries is fueling growth in the in vivo toxicology market.

Key players in the in vivo toxicology market are focusing on the development of advanced solutions, such as secure cloud-based real-time data platforms, to streamline study management and accelerate decision-making. These platforms allow researchers and clients to access toxicology study data, milestones, planning tools, and documents remotely and securely, enhancing collaboration and transparency. For instance, in March 2023, Charles River Laboratories International Inc., a U.S.-based contract research organization, launched Apollo, a secure cloud-based platform that provides real-time access to toxicology study data. Designed to support in vivo general toxicology studies, Apollo offers tools for data visualization, planning, and milestone tracking, enabling faster and more informed decision-making. The platform also helps streamline project planning and budget estimation throughout the drug development process. By digitizing toxicology workflows, Apollo improves precision, efficiency, and collaboration in in vivo research.

In October 2023, ETAP Lab SAS, a France-based preclinical contract research organization (CRO), acquired Syncrosome SAS, a France-based preclinical CRO specializing in in vivo pharmacology for cardiopulmonary pathologies. Through this acquisition, ETAP Lab SAS aims to enhance its cardiovascular and pulmonary disease model capabilities and expand its service portfolio. Syncrosome SAS provides in vivo R&D services in cardiology and pneumology.

Major companies operating in the in vivo toxicology market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Sigma-Aldrich Co. LLC, Eurofins Scientific SE, Agilent Technologies Inc., WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Jubilant Life Sciences Limited, Evotec SE, The Jackson Laboratory, Inotiv Inc., Transcure Bioservices Pvt. Ltd.

North America was the largest region in the in-vivo toxicology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo toxicology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in vivo toxicology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in vivo toxicology market consists of revenues earned by entities by providing services such as neurotoxicity assessment, dermal toxicity testing, ocular toxicity testing, and local tolerance testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The in vivo toxicology market also includes sales of anesthesia systems, telemetry devices, blood collection and sampling tools, drug delivery systems, and environmental control equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vivo Toxicology Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses in vivo toxicology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in vivo toxicology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in vivo toxicology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Consumables; Instruments
• 2) By Testing Types: Chronic Toxicity Testing; Sub-Chronic Toxicity Testing; Sub-Acute Toxicity Testing; Acute Toxicity Testing
• 3) By Methodology: In Vivo Animal Models; Genetically Modified Organisms; Non-Human Primate Studies; Rodent Models; Larger Mammals
• 4) By Application: Immunotoxicity; Systemic Toxicity; Carcinogenicity; Genotoxicity; Developmental And Reproductive Toxicity (DART); Other Applications
• 5) By End-User: Pharmaceutical Companies; Biosimilars Manufacturers; Contract Research Organizations (CROs); Academic And Research Institutions; Biotechnology Firms
• Subsegments:
• 1) By Consumables: Animal Models; Reagents And Kits; Assay Kits; Toxicology Testing Media; Antibodies; Biochemicals; Buffers And Solutions; Disposable Labware; Animal Feed; Diluents
• 2) By Instruments: Imaging Systems; Flow Cytometers; PCR Machines; Spectrophotometers; Microscopes; Analyzers; Centrifuges; Incubators; Animal Monitoring Systems; Automated Liquid Handling Systems
• Companies Mentioned: Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings (Labcorp); Sigma-Aldrich Co. LLC; Eurofins Scientific SE; Agilent Technologies Inc.; WuXi AppTec Co. Ltd.; Charles River Laboratories International Inc.; PerkinElmer Inc.; Jubilant Life Sciences Limited; Evotec SE; The Jackson Laboratory; Inotiv Inc.; Transcure Bioservices Pvt. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.